Evidence map›Paper›PMID 38790204›Full record

ArticleGenes2024

A Simple Nonviral Method to Generate Human Induced Pluripotent Stem Cells Using SMAR DNA Vectors.

Anna Hartley, Luisa Burger, Cornelia L Wincek, Lieke Dons, Tracy Li, Annabel Grewenig, Toros Taşgın, Manuela Urban, Alicia Roig-Merino, Mehrnaz Ghazvini and 1 more

Abstract read
In one paragraph

Article in Genes, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Anna HartleyDNA Vector Laboratory, German Cancer Research Center, 69120 Heidelberg, Germany.ORCID 0000-0002-5674-4880
Luisa BurgerDNA Vector Laboratory, German Cancer Research Center, 69120 Heidelberg, Germany.ORCID 0009-0000-6256-5267
Cornelia L WincekDNA Vector Laboratory, German Cancer Research Center, 69120 Heidelberg, Germany.ORCID 0009-0009-3152-6658
Lieke DonsErasmus MC iPS Core Facility, Erasmus Medical Centre, 3015 GD Rotterdam, The Netherlands.
Tracy LiErasmus MC iPS Core Facility, Erasmus Medical Centre, 3015 GD Rotterdam, The Netherlands.
Annabel GrewenigDNA Vector Laboratory, German Cancer Research Center, 69120 Heidelberg, Germany.
Toros TaşgınDNA Vector Laboratory, German Cancer Research Center, 69120 Heidelberg, Germany.
Manuela UrbanDNA Vector Laboratory, German Cancer Research Center, 69120 Heidelberg, Germany.
Alicia Roig-MerinoDNA Vector Laboratory, German Cancer Research Center, 69120 Heidelberg, Germany.
Mehrnaz GhazviniErasmus MC iPS Core Facility, Erasmus Medical Centre, 3015 GD Rotterdam, The Netherlands.
Richard P HarbottleDNA Vector Laboratory, German Cancer Research Center, 69120 Heidelberg, Germany.ORCID 0000-0002-3332-8024

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Induced pluripotent stem cells (iPSCs) are a powerful tool for biomedical research, but their production presents challenges and safety concerns. Yamanaka and Takahashi revolutionised the field by demonstrating that somatic cells could be reprogrammed into pluripotent cells by overexpressing four key factors for a sufficient time. iPSCs are typically generated using viruses or virus-based methods, which have drawbacks such as vector persistence, risk of insertional mutagenesis, and oncogenesis. The application of less harmful nonviral vectors is limited as conventional plasmids cannot deliver the levels or duration of the factors necessary from a single transfection. Hence, plasmids that are most often used for reprogramming employ the potentially oncogenic Epstein-Barr nuclear antigen 1 (EBNA-1) system to ensure adequate levels and persistence of expression. In this study, we explored the use of nonviral SMAR DNA vectors to reprogram human fibroblasts into iPSCs. We show for the first time that iPSCs can be generated using nonviral plasmids without the use of EBNA-1 and that these DNA vectors can provide sufficient expression to induce pluripotency. We describe an optimised reprogramming protocol using these vectors that can produce high-quality iPSCs with comparable pluripotency and cellular function to those generated with viruses or EBNA-1 vectors.

Indexed as

Cellular ReprogrammingFibroblastsGenetic VectorsInduced Pluripotent Stem CellsPlasmidsCells, CulturedEpstein-Barr Virus Nuclear AntigensHumansTransfectionEBV-encoded nuclear antigen 1Epstein-Barr Virus Nuclear AntigensiPSCnonviralreprogrammingS/MARSMAR DNA vectorstem cells

Identifiers

PMID38790204
PMCPMC11121542

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.